162 related articles for article (PubMed ID: 406478)
1. [Synergistic therapeutic effect of adriamycin with 5-fluor-uracil, with prednisolon and with cyclophosphamide on chemically induced mammary cancer of the rat (author's transl)].
Fiebig HH; Schmähl D
Klin Wochenschr; 1977 May; 55(9):445-50. PubMed ID: 406478
[No Abstract] [Full Text] [Related]
2. Endocrine and cytostatic treatment of experimental mammary cancer.
Fiebig HH; Schmähl D
Recent Results Cancer Res; 1980; 71():80-95. PubMed ID: 6768114
[No Abstract] [Full Text] [Related]
3. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
Michlmayr G; Kratzer H; Denz H; Huber H
Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
[TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor effects of adriamycin, 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on rat mammary cancer induced by 7,12-dimethyl benz (A) anthracene].
Tominaga T; Kitamura M; Yoshida Y; Kosaki G
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1663-8. PubMed ID: 6433800
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
Raevskiĭ IG
Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
[No Abstract] [Full Text] [Related]
6. The effect of ovariectomy, tamoxifen and the combination adriamycin and 5-FU on 7,12-dimethylbenz(a)anthracene induced mammary cancer of the rat.
Fiebig HH; Schmähl D
Oncology; 1977; 34(2):58-61. PubMed ID: 408773
[No Abstract] [Full Text] [Related]
7. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
Collis CH
Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
[No Abstract] [Full Text] [Related]
8. Rationale for adjuvant chemotherapy.
Schabel FM
Cancer; 1977 Jun; 39(6 Suppl):2875-82. PubMed ID: 141322
[No Abstract] [Full Text] [Related]
9. Inhibitory effect of levamisole and adriamycin on rat mammary cancer induced by 7,12-dimethylbenz(a)anthracene.
Tominaga T; Kitamura M; Saito T; Itoh I
Eur J Cancer (1965); 1980 Nov; 16(11):1489-93. PubMed ID: 6785092
[No Abstract] [Full Text] [Related]
10. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy against human melanoma in the hamster cheek pouch.
Dufour FD; Okada GT; Mah SG; Morton DL
J Surg Oncol; 1980; 15(4):355-61. PubMed ID: 7453185
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vagina.
Piver MS; Barlow JJ; Xynos FP
Am J Obstet Gynecol; 1978 Jun; 131(3):311-3. PubMed ID: 78671
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
Nowak C; Arnold W; Henneberger G; Tanneberger S
Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
[TBL] [Abstract][Full Text] [Related]
14. Interaction between human lymphoblastoid interferon and chemotherapeutic agents in vitro.
Takahashi I; Oda Y; Lai M; Fukumoto M; Nishimura M; Yorimitsu S; Kitajima K; Kimura I
Acta Med Okayama; 1984 Dec; 38(6):501-4. PubMed ID: 6335349
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
Prindull G; Poppe H; Jentsch E; Schauer A
Unfallheilkunde; 1981 Dec; 84(12):524-5. PubMed ID: 6948465
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
[No Abstract] [Full Text] [Related]
18. [Efficiency and side effects of adriamycin-cyclophosphamide therapy compared to a triple combination of cyclophosphamide, methotrexate and 5-fluoro-uracil].
Weymar P; Schulz KD; Noldus B; Schmidt-Rhode P
Arch Gynecol; 1979 Jul; 228(1-4):445-6. PubMed ID: 485425
[No Abstract] [Full Text] [Related]
19. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
[TBL] [Abstract][Full Text] [Related]
20. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
De Lena M; Brambilla C; Morabito A; Bonadonna G
Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
